Logo image of BIOX

BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Analyst Earnings Estimates

NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock - Currency: USD

3.32  -0.05 (-1.48%)

After market: 3.31 -0.01 (-0.3%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BIOX revenue by date.BIOX revenue by date.
328.4M
58.88%
415.095M
26.40%
464.829M
11.98%
379.8M
-18.29%
407.52M
7.30%
477.16M
17.09%
521.22M
9.23%
590.78M
13.35%
665.35M
12.62%
738.99M
11.07%
773.16M
4.62%
EBITDA
YoY % growth
BIOX ebitda by date.BIOX ebitda by date.
41.59M
1.76%
71.765M
72.55%
64.497M
-10.13%
53.55M
-16.97%
72.862M
36.06%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BIOX ebit by date.BIOX ebit by date.
32.4M
-6.36%
52.375M
61.65%
43.202M
-17.51%
23.307M
-46.05%
46.308M
98.69%
102.31M
120.93%
76.704M
-25.03%
101.69M
32.57%
118.73M
16.76%
128.32M
8.08%
134.44M
4.77%
Operating Margin
BIOX operating margin by date.BIOX operating margin by date.
9.87%12.62%9.29%6.14%11.36%21.44%14.72%17.21%17.84%17.36%17.39%
EPS
YoY % growth
BIOX eps by date.BIOX eps by date.
-0.14
23.37%
0.25
275.89%
0.06
-76.21%
-0.07
-212.37%
0.21
415.38%
0.42
100.00%
0.57
36.59%
0.84
46.43%
1.01
20.73%
1.10
9.09%
1.15
4.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.08
355.00%
0.03
134.00%
0.13
1,373.33%
-0.16
-716.00%
0.11
46.67%
Revenue
Q2Q % growth
114.06M
-8.02%
107.1M
15.66%
127.5M
19.38%
64.26M
6.04%
127.5M
11.78%
EBITDA
Q2Q % growth
18.717M
-41.30%
N/AN/AN/AN/A
EBIT
Q2Q % growth
14.654M
38.36%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.02
-114.29%
-0.150.1386.93%
Q2 2025
Q2Q % growth
0.01
-52.63%
0.09-0.08-89.82%
Q1 2025
Q2Q % growth
-0.09
-28.57%
-0.01-0.08-1,076.47%
Q4 2024
Q2Q % growth
-0.03
50.00%
0.25-0.28-112.05%
Q3 2024
Q2Q % growth
0.14
-68.18%
0.17-0.03-19.26%
Q2 2024
Q2Q % growth
0.02
113.57%
0.09-0.07-79.75%
Q1 2024
Q2Q % growth
-0.07
-975.00%
0.06-0.13-219.35%
Q4 2023
Q2Q % growth
-0.06
27.71%
0.05-0.11-227.88%
Q3 2023
Q2Q % growth
0.44
378.48%
-0.030.471,759.13%
Q2 2023
Q2Q % growth
-0.14
-275.00%
0.07-0.21-303.34%
Q1 2023
Q2Q % growth
0.01
-60.00%
0.05-0.04-83.66%
Q4 2022
Q2Q % growth
-0.08
-515.00%
0.16-0.25-150.86%
Q3 2022
Q2Q % growth
-0.16
-409.68%
-0.08-0.08-99.87%
Q2 2022
Q2Q % growth
0.08
370.59%
0.050.0349.39%
Q1 2022
Q2Q % growth
0.02
110.53%
0.09-0.07-78.80%
Q4 2021
Q2Q % growth
0.02
-66.67%
0.27-0.25-92.60%
Q3 2021
Q2Q % growth
-0.03
65.56%
-0.050.0239.22%
Q2 2021
Q2Q % growth
0.02
-94.52%
0.37-0.35-95.37%
Q1 2021
Q2Q % growth
-0.19
-111.11%
0.08-0.27-332.84%
Q4 2020
Q2Q % growth
0.06
-80.65%
0.22-0.16-72.64%
Q3 2020
Q2Q % growth
-0.09 -0.120.0323.27%
Q2 2020
Q2Q % growth
0.31 0.34-0.03-7.90%
BIOX Yearly EPS VS EstimatesBIOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 0.6 0.8 1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
60.6M
-27.86%
65.212M-4.612M-7.07%
Q2 2025
Q2Q % growth
106.8M
-23.82%
132.09M-25.29M-19.15%
Q1 2025
Q2Q % growth
92.6M
-20.58%
111.44M-18.84M-16.91%
Q4 2024
Q2Q % growth
124M
18.43%
138.07M-14.07M-10.19%
Q3 2024
Q2Q % growth
84M
-10.26%
100.47M-16.47M-16.39%
Q2 2024
Q2Q % growth
140.2M
50.75%
119.33M20.87M17.49%
Q1 2024
Q2Q % growth
116.6M
-7.90%
126.29M-9.69M-7.67%
Q4 2023
Q2Q % growth
104.7M
1.16%
109.81M-5.11M-4.65%
Q3 2023
Q2Q % growth
93.605M
38.88%
90.181M3.424M3.80%
Q2 2023
Q2Q % growth
93M
2.09%
93.824M-824K-0.88%
Q1 2023
Q2Q % growth
126.6M
90.66%
83.63M42.97M51.38%
Q4 2022
Q2Q % growth
103.5M
27.62%
96.792M6.708M6.93%
Q3 2022
Q2Q % growth
67.4M
89.86%
45.631M21.769M47.71%
Q2 2022
Q2Q % growth
91.1M
89.79%
71.384M19.716M27.62%
Q1 2022
Q2Q % growth
66.4M
57.72%
51.214M15.186M29.65%
Q4 2021
Q2Q % growth
81.1M
68.61%
55.007M26.093M47.44%
Q3 2021
Q2Q % growth
35.5M
38.13%
27.967M7.533M26.94%
Q2 2021
Q2Q % growth
48M
-22.95%
68.952M-20.952M-30.39%
Q1 2021
Q2Q % growth
42.1M
15.98%
40.8M1.3M3.19%
Q4 2020
Q2Q % growth
48.1M
-3.02%
50.813M-2.713M-5.34%
Q3 2020
Q2Q % growth
25.7M
37.43%
20.4M5.3M25.98%
Q2 2020
Q2Q % growth
62.3M
-0.32%
71.4M-9.1M-12.75%
Q1 2020
Q2Q % growth
36.3M
22.64%
%
BIOX Yearly Revenue VS EstimatesBIOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -37.5% 0% 39.06%
Revenue0% -5.84% 0% -2.7%